Literature DB >> 15822173

Fat cells: afferent and efferent messages define new approaches to treat obesity.

Max Lafontan1.   

Abstract

For a long time neural and endocrine messages were studied for their impact on adipocyte metabolism and control of storage/release of fatty acids. In fact, bidirectional communication exists between adipocytes and other tissues. Several molecules secreted from adipocytes are involved in fat cell signaling to other tissues. Adipocyte products could initiate antagonistic effects on target tissues. Fat cells produce peptides that can elicit insulin resistance, such as tumor necrosis factor-alpha and resistin, as well as hormones that can improve insulin resistance, such as leptin and adiponectin. Secretion of complement proteins, proinflammatory cytokines, procoagulant, and acute phase reactant proteins have also been observed in adipocytes. There is much to learn about how these signals function. It is unlikely that all the adipocyte's endocrine and paracrine signals have been identified. Putative pharmacological strategies aiming at modulation of afferent and efferent fat cell messages are reviewed and discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15822173     DOI: 10.1146/annurev.pharmtox.45.120403.095843

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  32 in total

1.  Adipokine expression in brown and white adipocytes in response to hypoxia.

Authors:  A Wree; A Mayer; S Westphal; A Beilfuss; A Canbay; R R Schick; G Gerken; P Vaupel
Journal:  J Endocrinol Invest       Date:  2011-09-27       Impact factor: 4.256

2.  Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: a role for transcriptional regulation of processing.

Authors:  P Wang; J Keijer; A Bunschoten; F Bouwman; J Renes; E Mariman
Journal:  Diabetologia       Date:  2006-08-04       Impact factor: 10.122

3.  Cardiovascular risk factors in middle age obese Indians: a cross-sectional study on association of per cent body fat and intra-abdominal fat mass.

Authors:  Jaspal Singh Sandhu; Vandana Esht; Shweta Shenoy
Journal:  Heart Asia       Date:  2012-02-21

4.  The pathophysiology of obesity and its clinical manifestations.

Authors:  Richard N Redinger
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-11

5.  Role of transcription factor NFAT in glucose and insulin homeostasis.

Authors:  Teddy T C Yang; Hee Yun Suk; Xiaoyong Yang; Opeyemi Olabisi; Raymond Y L Yu; Jorge Durand; Linda A Jelicks; Ja-Young Kim; Philipp E Scherer; Yuhua Wang; Yun Feng; Luciano Rossetti; Isabella A Graef; Gerald R Crabtree; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2006-08-14       Impact factor: 4.272

Review 6.  Obesity, cardiovascular disease, and role of vitamin C on inflammation: a review of facts and underlying mechanisms.

Authors:  Mohammed S Ellulu
Journal:  Inflammopharmacology       Date:  2017-02-06       Impact factor: 4.473

Review 7.  Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-Analysis.

Authors:  Moein Askarpour; Dana Khani; Ali Sheikhi; Ehsan Ghaedi; Shahab Alizadeh
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

8.  Activator of G protein signaling 3 null mice: I. Unexpected alterations in metabolic and cardiovascular function.

Authors:  Joe B Blumer; Kevin Lord; Thomas L Saunders; Alejandra Pacchioni; Cory Black; Eric Lazartigues; Kurt J Varner; Thomas W Gettys; Stephen M Lanier
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

9.  A cholecystokinin-1 receptor agonist (CCK-8) mediates increased permeability of brain barriers to leptin.

Authors:  V Cano; B Merino; L Ezquerra; B Somoza; M Ruiz-Gayo
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

10.  Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity.

Authors:  Paula Stucchi; Victoria Cano; Mariano Ruiz-Gayo; María S Fernández-Alfonso
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.